Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets.

Vlachou M, Geraniou E, Siamidi A.

Acta Pharm. 2020 Mar 1;70(1):49-61. doi: 10.2478/acph-2020-0010.

PMID:
31677367
2.

Utilization of a single experimental design for the optimization of furosemide modified release tablet formulations.

Vlachou M, Siamidi A, Dotsikas Y.

Curr Drug Deliv. 2019 Oct 29. doi: 10.2174/1567201816666191029130324. [Epub ahead of print]

PMID:
31663479
3.

Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide.

Vlachou M, Kikionis S, Siamidi A, Kyriakou S, Tsotinis A, Ioannou E, Roussis V.

Pharmaceutics. 2019 Sep 17;11(9). pii: E480. doi: 10.3390/pharmaceutics11090480.

4.

Modified In Vitro Release of Melatonin Loaded in Nanofibrous Electrospun Mats Incorporated Into Monolayered and Three-Layered Tablets.

Vlachou M, Kikionis S, Siamidi A, Tragou K, Ioannou E, Roussis V, Tsotinis A.

J Pharm Sci. 2019 Feb;108(2):970-976. doi: 10.1016/j.xphs.2018.09.035. Epub 2018 Oct 9.

PMID:
30312723
5.

Fabrication and Characterization of Electrospun Nanofibers for the Modified Release of the Chronobiotic Hormone Melatonin.

Vlachou M, Kikionis S, Siamidi A, Tragou K, Kapoti S, Ioannou E, Roussis V, Tsotinis A.

Curr Drug Deliv. 2019;16(1):79-85. doi: 10.2174/1567201815666180914095701.

6.

Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin Complexes.

Vlachou M, Papamichael M, Siamidi A, Fragouli I, Afroudakis PA, Kompogennitaki R, Dotsikas Y.

Int J Mol Sci. 2017 Jul 28;18(8). pii: E1641. doi: 10.3390/ijms18081641.

7.

In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II).

Vlachou M, Siamidi A, Spaneas D, Lentzos D, Ladia P, Anastasiou K, Papanastasiou I, Foscolos AS, Georgiadis MO, Karalis V, Kellici T, Mavromoustakos T.

Drug Res (Stuttg). 2017 Nov;67(11):653-660. doi: 10.1055/s-0043-114012. Epub 2017 Jul 19.

PMID:
28724167
8.

In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I).

Vlachou M, Siamidi A, Diamantidi E, Iliopoulou A, Papanastasiou I, Ioannidou V, Kourbeli V, Foscolos AS, Vocat A, Cole ST, Karalis V, Kellici T, Mavromoustakos T.

Drug Res (Stuttg). 2017 Aug;67(8):447-450. doi: 10.1055/s-0042-121491. Epub 2017 May 30.

PMID:
28561241

Supplemental Content

Loading ...
Support Center